Dr. Martine A. Rothblatt Ph.D.

United Therapeutics

Dr. Martine A. Rothblatt is Chair, CEO & Founder of United Therapeutics Corp., a Chief Executive Officer at Revivicor, Inc. and a President & CEOat Lung Biotechnology PBC. Martine was previously chairman & CEO of SIRIUS Satellite Radio, Inc. She also served on the board at Synthetic Genomics, Inc. She is currently on the Board of Directors at United Therapeutics Europe Ltd., Beta Technologies, Inc. and The Kennedy Center Corporate Fund. In 2021, the National Business Aviation Association (NBAA) selected her for its highest honor, the Meritorious Service to Aviation Award, for her fostering of aviation weather information on the flight deck and of advanced air mobility such as electric helicopters. She received her graduate degree from the University of California, Los Angeles, an MBA from the University of California, Los Angeles and a PhD from the University of London.

Year appointed: 1996

Register for this year’s Action for Impact Summit happening on September 25, 2024!